Company Filing History:
Years Active: 2004-2006
Title: Innovations of Charles R. Bredl
Introduction
Charles R. Bredl is an accomplished inventor based in Kent, WA (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds with selective hydrolytic potentials. His work has implications for various biological systems, showcasing his innovative approach to solving complex problems.
Latest Patents
Charles R. Bredl holds 2 patents. His latest patents include "Compounds having selective hydrolytic potentials." These patents disclose compounds that possess selective stability and are capable of undergoing programmed hydrolysis in biological systems. The disclosed compounds have a structure of formula I, which highlights their unique properties and potential applications.
Career Highlights
Bredl is currently associated with Cell Therapeutics, Inc., where he continues to push the boundaries of innovation in his field. His work at the company reflects his commitment to advancing medical science through the development of novel therapeutic compounds.
Collaborations
Some of his notable coworkers include David J. Porubek and Anil M. Kumar. Their collaborative efforts contribute to the innovative environment at Cell Therapeutics, Inc., fostering advancements in biotechnology.
Conclusion
Charles R. Bredl's contributions to the field of biotechnology through his patents and work at Cell Therapeutics, Inc. exemplify the spirit of innovation. His research on compounds with selective hydrolytic potentials holds promise for future applications in biological systems.